DR. MARK BARRY ABELSON, M.D.
Medical Practice at Haverhill St, Andover, MA
License number
Massachusetts 37429
Category
Medical Practice
Type
Ophthalmology
Address
Address
138 Haverhill St STE 104, Andover, MA 01810
Phone
(978) 475-0705
(978) 475-0008 (Fax)
(978) 475-0008 (Fax)
Personal information
See more information about MARK BARRY ABELSON at radaris.comName
Address
Phone
184 Pond St, Sharon, MA 02067
26 Phillips St, Andover, MA 01810
20 Staniford St, Boston, MA 02114
26 Phillips St, Andover, MA 01810
2 Hawthorne Pl, Boston, MA 02114
Professional information
Treatment Of Ocular Hypertension With Class I Calcium Channel Blocking Agents
US Patent:
4981871, Jan 1, 1991
Filed:
May 15, 1987
Appl. No.:
7/050917
Inventors:
Mark B. Abelson - Andover MA
International Classification:
A61K 31275
US Classification:
514523
Abstract:
Elevated intraocular pressure in a mammalian eye is lowered by administering to the eye an amount of a Class I calcium channel blocking agent effective to lower the elevated intraocular pressure. A preferred calcium channel blocking agent is verapamil and the preferred mode of administration is topical directly to the eye, e. g. , with drops.
Dr. Mark B Abelson, Andover MA - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Andover Eye Associates
138 Haverhill St SUITE 104, Andover 01810
(978) 475-0705 (Phone)
138 Haverhill St SUITE 104, Andover 01810
(978) 475-0705 (Phone)
Certifications:
Ophthalmology, 1976
Awards:
Healthgrades Honor Roll
Languages:
English, French
Hospitals:
Andover Eye Associates
138 Haverhill St SUITE 104, Andover 01810
Lawrence General Hospital
1 General St, Lawrence 01842
Winchester Hospital
41 Highland Ave, Winchester 01890
138 Haverhill St SUITE 104, Andover 01810
Lawrence General Hospital
1 General St, Lawrence 01842
Winchester Hospital
41 Highland Ave, Winchester 01890
Education:
Medical School
McGill University Faculty Of Medicine
Graduated: 1970
Royal Victoria Hospital McGill
Graduated: 1971
Graduated: 1974
Mass Eye Ear Infrm/Eye Rsch
Graduated: 1976
McGill University Faculty Of Medicine
Graduated: 1970
Royal Victoria Hospital McGill
Graduated: 1971
Graduated: 1974
Mass Eye Ear Infrm/Eye Rsch
Graduated: 1976
Ophthalmic Formulations Of Cetirizine And Methods Of Use
US Patent:
2010024, Sep 23, 2010
Filed:
Mar 15, 2010
Appl. No.:
12/724128
Inventors:
Mark B. Abelson - Andover MA, US
Matthew J. Chapin - Amesbury MA, US
Paul Gomes - Haverhill MA, US
George Minno - Suwanee GA, US
Jackie Nice - Medford MA, US
Matthew J. Chapin - Amesbury MA, US
Paul Gomes - Haverhill MA, US
George Minno - Suwanee GA, US
Jackie Nice - Medford MA, US
Assignee:
Aciex Therapeutics, Inc. - Westborough MA
International Classification:
A61K 31/56, A61K 31/4965, A61P 27/02, A61P 37/08
US Classification:
514171, 51425504
Abstract:
The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
Compositions And Method For Treating Red Eye
US Patent:
4315024, Feb 9, 1982
Filed:
Aug 8, 1980
Appl. No.:
6/176525
Inventors:
Mark B. Abelson - Andover MA
Assignee:
Cooper Laboratories, Inc. - Palo Alto CA
International Classification:
A01N 4350, A01N 4356
US Classification:
424273R
Abstract:
A method for treating red eye by administering to the afflicted eye a composition comprising an anti-inflammatory amount of an antagonist for H. sub. 2 receptors in the eye, preferably cimetidine, and a non-toxic, pharmaceutically acceptable, ophthalmological carrier.
Compositions For The Treatment And Prevention Of Eyelid Swelling
US Patent:
2007026, Nov 15, 2007
Filed:
Apr 26, 2007
Appl. No.:
11/796278
Inventors:
Matthew Chapin - Amesbury MA, US
Mark Abelson - Andover MA, US
Keith Lane - Somerville MA, US
Akimitsu Makino - Arlington MA, US
Mark Abelson - Andover MA, US
Keith Lane - Somerville MA, US
Akimitsu Makino - Arlington MA, US
International Classification:
A61K 31/70, A61K 31/045, A61K 33/14
US Classification:
424448000, 424680000, 514023000, 514053000, 514738000
Abstract:
The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.
Ophthalmic Formulations, Methods Of Manufacture, And Methods Of Using Same
US Patent:
2010031, Dec 9, 2010
Filed:
Jun 4, 2010
Appl. No.:
12/794315
Inventors:
Matthew J. Chapin - Amesbury MA, US
George Minno - Suwanee GA, US
Jackie Nice - Medford MA, US
Mark B. Abelson - Andover MA, US
George Minno - Suwanee GA, US
Jackie Nice - Medford MA, US
Mark B. Abelson - Andover MA, US
Assignee:
Aciex Therapeutics, Inc. - Westborough MA
International Classification:
A61K 31/717, A61P 27/04
US Classification:
514 57
Abstract:
The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye. Methods of manufacture are also provided.
Treatment Of Low-Tension Glaucoma By Topical Administration Of Calcium Channel Blocking Agents
US Patent:
5435998, Jul 25, 1995
Filed:
Aug 3, 1994
Appl. No.:
8/285301
Inventors:
Mark B. Abelson - Andover MA
International Classification:
A61K 31135
US Classification:
424 7804
Abstract:
Low-tension glaucoma is treated by topical administration to the eye of an amount of a calcium channel blocking agent effective to increase blood flow to the optic nerve head. Calcium channel blocking agents of Class I are especially useful, and among these a preferred agent is verapamil hydrochloride.
Formulations And Methods For Treating Dry Eye
US Patent:
2007029, Dec 27, 2007
Filed:
Jun 18, 2007
Appl. No.:
11/820461
Inventors:
George Ousler - North Andover MA, US
Matthew Chapin - Amesbury MA, US
Mark Abelson - Andover MA, US
Matthew Chapin - Amesbury MA, US
Mark Abelson - Andover MA, US
International Classification:
A61K 49/00, A61K 31/133, A61K 31/192, A61K 31/196, A61K 31/381, A61K 31/403, A61P 29/00, C12N 9/99, A61P 27/04, A61K 31/405, A61K 31/717, A61K 31/721, A61K 38/02
US Classification:
424009100, 435184000, 514002000, 514413000, 514420000, 514448000, 514567000, 514057000, 514570000, 514059000, 514663000
Abstract:
The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye.
Ophthalmic Formulations Of Fluticasone And Methods Of Use
US Patent:
2011010, May 5, 2011
Filed:
Jun 4, 2010
Appl. No.:
12/794320
Inventors:
Matthew J. Chapin - Amesbury MA, US
George Minno - Suwanee GA, US
Jackie Nice - Medford MA, US
Paul Gomes - Haverhill MA, US
Mark Barry Abelson - Andover MA, US
George Minno - Suwanee GA, US
Jackie Nice - Medford MA, US
Paul Gomes - Haverhill MA, US
Mark Barry Abelson - Andover MA, US
Assignee:
Aciex Therapeutics, Inc. - Westborough MA
International Classification:
A61K 31/56, A61P 27/02, A61P 37/08
US Classification:
514180
Abstract:
The present invention provides ophthalmic formulations of fluticasone that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic conjunctivitis in a subject in need of such treatment by topical application of the fluticasone formulations of the invention directly to the eye.
Treatment Of Vascular Disorders Of The Posterior Segment Of The Eye By Topical Administration Of Calcium Channel Blocking Agents
US Patent:
5431907, Jul 11, 1995
Filed:
Aug 3, 1994
Appl. No.:
8/285300
Inventors:
Mark B. Abelson - Andover MA
Richard L. Giovanoni - E. Taunton MA
Richard L. Giovanoni - E. Taunton MA
International Classification:
A61K 3135
US Classification:
424 7804
Abstract:
Ischemic disorders of the retina and associated tissues of the posterior segment of the eye are treated by topical administration to the eye of an amount of a calcium channel blocking agent effective to increase blood flow to those tissues. Calcium channel blocking agents of Class I are especially useful, and among these a preferred agent is verapamil hydrochloride.